USANA Health Sciences, Inc. (NYSE:USNA) Stock Holdings Boosted by Martingale Asset Management L P

Martingale Asset Management L P lifted its position in USANA Health Sciences, Inc. (NYSE:USNA) by 2.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,732 shares of the company’s stock after buying an additional 340 shares during the period. Martingale Asset Management L P owned approximately 0.09% of USANA Health Sciences worth $634,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of USNA. American Century Companies Inc. grew its holdings in USANA Health Sciences by 12.3% during the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock worth $7,229,000 after acquiring an additional 17,460 shares during the period. Assenagon Asset Management S.A. raised its holdings in shares of USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after purchasing an additional 14,756 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in USANA Health Sciences by 14,068.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after purchasing an additional 38,547 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in USANA Health Sciences by 24.4% during the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after buying an additional 191,289 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C grew its position in USANA Health Sciences by 297.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after buying an additional 22,251 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, DA Davidson cut their price objective on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, October 23rd.

Insider Activity

In related news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

USANA Health Sciences Trading Up 4.0 %

USNA stock opened at $40.07 on Tuesday. USANA Health Sciences, Inc. has a one year low of $34.15 and a one year high of $54.81. The firm has a 50-day moving average of $37.83 and a two-hundred day moving average of $41.34. The firm has a market capitalization of $763.73 million, a PE ratio of 14.16, a P/E/G ratio of 1.31 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter in the prior year, the firm earned $0.59 EPS. On average, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.